| Income Statement for Savient Pharmaceuticals Inc (SVNT) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 14,024 | 47,514 | 87,794 | 113,275 | 132,525 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 4,408 | (3,538) | (13,687) | (30,422) | (20,122) | | Gross Operating Profit | 18,432 | 43,976 | 74,107 | 82,853 | 112,403 | | | Selling/General/Admin Expense | (31,123) | (34,601) | (52,545) | (62,308) | (55,485) | | Research & Development | (50,870) | (21,412) | (19,583) | (27,800) | (31,797) | | EBITDA | (63,561) | (12,037) | 1,979 | (7,255) | 25,121 | | Depreciation & Amortization | (5,613) | (4,968) | (7,682) | (10,746) | (8,673) | | EBIT | (69,174) | (17,005) | (5,703) | (18,001) | 16,448 | | Interest Income | 8,749 | - | - | - | - | | Other Income, Net | (537) | 15,566 | 14,359 | (756) | 3,635 | | Total Income Avail For Interest Expense | (60,962) | (1,439) | 8,656 | (20,719) | 20,083 | | Interest Expense | - | - | - | - | - | | Pre-Tax Income | (60,962) | (1,439) | 8,656 | (20,719) | 20,083 | | Income Taxes | 11,807 | (25) | (2,629) | (14,553) | (6,161) | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (49,155) | (1,464) | 6,027 | (35,272) | 13,922 | | Net Income from Discontinued Operations | 487 | 61,789 | (59) | - | - | | Net Income from Total Operations | (48,668) | 60,325 | 5,968 | (35,272) | 13,922 | | | Normalized Income | (49,155) | (1,464) | 6,027 | (33,310) | 13,922 | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | - | - | (1,962) | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (48,668) | 60,325 | 5,968 | (35,272) | 13,922 | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -0.94 | -0.03 | 0.10 | -0.59 | 0.24 | | Basic EPS from Discontinued Operations | 0.01 | 1.06 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -0.93 | 1.03 | 0.10 | -0.59 | 0.24 | | | Diluted EPS from Continuing Operations | -0.94 | -0.03 | 0.10 | -0.59 | 0.23 | | Diluted EPS from Discontinued Operations | 0.01 | 1.06 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -0.93 | 1.03 | 0.10 | -0.59 | 0.23 | | | |
